User Settings

Targeting Antithrombin to Treat Hemophilia

Margaret V. Ragni-2015-07-22-New England Journal of Medicine
30

TL;DRAbstract

The prophylactic treatment of hemophilia involves the replacement of factor VIII or IX in affected persons. A new approach involves the depletion of the clot inhibitor antithrombin.

Chat with Paper

AI Agents for this Paper

The prophylactic treatment of hemophilia involves the replacement of factor VIII or IX in affected persons. A new approach involves the depletion of the clot inhibitor antithrombin.

Keywords

MedicineAntithrombinAntithrombinsFactor IXIntensive care medicineInternal medicineHeparin

Chat

Click to start Chat